Haemonetics Corporation (NYSE: HAE) received U.S. Food and Drug Administration approval to expand labeling for its VASCADE MVP XL venous ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE